je.st
news
Tag: biotech
Philadelphia biotech firm resolves debt dispute with cancer hospital
2015-08-06 00:33:46| Biotech - Topix.net
Avax Technologies , a Philadelphia-based biotechnology company developing cancer immunotherapy products, said Wednesday it has reached a settlement with the Cancer Treatment Centers of America to resolve its debt dispute with the cancer hospital network. Under the terms of the agreement, CTCA has agreed to settle its $5.8 million judgment against Avax in exchange for 860,000 shares of the company preferred Series A stock and a one-time payment of $1.5 million in cash.
Tags: firm
hospital
cancer
debt
Premarket Biotech Digest: Gilead HIV, Eliquis Trial Errors, Clinical Trial Phases
2015-08-04 07:51:25| Biotech - Topix.net
This may be FDA 101 for some people, but many lay investors may not be aware of the precise details; so I am providing this brief note following the FDA itself. All new drugs and almost all drugs applying for new indications must go through a clinical research where it is tested in human subjects prior to FDA approval.
Tags: trial
errors
clinical
digest
Biotech roundup: How many drugs has Seattle developed?
2015-08-04 03:46:37| Biotech - Topix.net
Seattle's booming biotech industry has its challenges, but those challenges haven't prevented the region over the years from growing in the number of companies and workers located here. An Xconomy article Monday morning attempted to boil down the region's biotech impact in terms of the end results - the drugs that come to market.
Tags: developed
drugs
seattle
biotech
Just Published: 'Global Royalty Financing Deals in Pharma, Biotech and Diagnostics 2010-2015'
2015-08-02 19:31:40| Biotech - Topix.net
Fast Market Research recommends "Global Royalty Financing Deals in Pharma, Biotech and Diagnostics 2010-2015" from Current Partnering, now available The Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2005-2015 report is your one-stop source for providing real-deal information on hundreds of transactions, including the technology licensed, royalty rates, license fees, upfront and milestone payments. This report provides details of the latest partnering deals which disclose a royalty rate, announced in the pharmaceutical, biotechnology and diagnostic sectors.
Tags: published
global
deals
financing
NantKwest's Successful IPO: An Indicator For The Biotech Industry, Both Good And Bad
2015-08-01 14:49:29| Biotech - Topix.net
The biotech industry is doing better than ever, and NantKwest's successful IPO shows that this demand is still growing. There remain concerns about whether biotech is in a golden age or a bubble.
Tags: good
bad
industry
successful
Sites : [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] next »